About the Authors

Tom H. M. Ottenhoff

t.h.m.ottenhoff@lumc.nl

Affiliation Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands

Stefan H. E. Kaufmann

Affiliation Deptartment of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany

Competing Interests

I have read the journal's policy and have the following conflicts: TO is co-inventor of an Mtb latency antigen patent, which is owned by LUMC. SHEK is co-inventor of the rBCGΔUreC:Hly vaccine candidate and of the vaccine antigen Rv3407, and member of the Scientific Advisory Boards of Intercell, Vienna, and Vakzine Projekt Management (VPM), Hannover.